About
HemaSense is Improving patient outcomes and reducing costs of percutaneous interventions by providing healthcare professionals the first early alert system for bleeding complications at the access site during post-op recovery. HemaSense is developing an access site monitor which is used during patient recovery to provide early detection and alert of subcutaneous bleeding events. The HemaSense monitor seamlessly integrates with existing patient recovery workflow and enables early, less costly interventions for patients when small amounts of blood are beginning to accumulate outside the femoral vessel.
Technologies
Outlook
Microsoft Office 365
WordPress.org
Mobile Friendly
Apache
Bootstrap Framework
Keywords
medical equipment manufacturing
medical device development
percutaneous interventions
clinical team expertise
medical device r&d
clinical background team
investor funding
monitoring device
disruptive medical technology
medical device prototyping
postoperative bleeding alert
early alert system for bleeding
healthcare technology
bleeding complication alert
medical device
early intervention technology
patient safety enhancement
medical device for bleeding
subcutaneous bleeding detection
cost reduction in healthcare
early bleeding detection system
b2b
product development
medical device patents
healthcare
post-procedure bleeding management
medical device under development
medical device innovation
post-op recovery
vascular access site monitoring
Company Information
-
Employees 4
-
Founded 2024
Location
E Phoenix Ave, Flagstaff, Arizona, United States, 86001
